Regeneron (NASDAQ: REGN) reported Q4 EPS of $11.44, $0.92 better than the analyst estimate of $10.52. Revenue for the quarter came in at $3.88 billion versus the consensus estimate of $3.77 billion.

For earnings history and earnings-related data on Regeneron (REGN) click here.